{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:30:55Z","timestamp":1774686655274,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,5,1]],"date-time":"1998-05-01T00:00:00Z","timestamp":893980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1998,5]]},"DOI":"10.1006\/clin.1998.4524","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T20:18:03Z","timestamp":1033935483000},"page":"168-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Elevated CD69 Expression on Naive Peripheral Blood T-Cells in Hyperthyroid Graves\u2019 Disease and Autoimmune Thyroiditis: Discordant Effect of Methimazole on HLA-DR and CD69"],"prefix":"10.1006","volume":"87","author":[{"given":"Alois","family":"Gessl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Waldh\u00e4usl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1998.4524_II984524RF1","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1084\/jem.164.6.1988","article-title":"Human T cell activation. III. Rapid induction of a phosphorylated 28 kD\/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens","volume":"164","author":"Hara","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1998.4524_II984524RF2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.178.2.537","article-title":"Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM\/CD69, a new member of the C-type animal lectin superfamily of signal transmitting receptors","volume":"178","author":"Lop\u00e9z-Cabrera","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1998.4524_II984524RF3","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.158.6.1895","article-title":"Transient expression of interleukin 2 receptors. Consequences for T cell growth","volume":"158","author":"Cantrell","year":"1983","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1998.4524_II984524RF4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0167-5699(91)90051-T","article-title":"T-cell memory: the connection between function, phenotype and migration pathways","volume":"12","author":"Mackay","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1998.4524_II984524RF5","first-page":"460","article-title":"Phenotypic changes associated with activation of CD45RA++","volume":"69","author":"Wallace","year":"1990","journal-title":"Immunology"},{"key":"10.1006\/clin.1998.4524_II984524RF6","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4049\/jimmunol.140.7.2171","article-title":"Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells","volume":"140","author":"Akbar","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1998.4524_II984524RF7","first-page":"15","article-title":"Preferential expression of IL-2 receptor subunits on memory populations within CD4++","volume":"72","author":"Taga","year":"1991","journal-title":"Immunology"},{"key":"10.1006\/clin.1998.4524_II984524RF8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/thy.1995.5.117","article-title":"Activated naive CD4+","volume":"5","author":"Gessl","year":"1995","journal-title":"Thyroid"},{"key":"10.1006\/clin.1998.4524_II984524RF9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1093\/intimm\/3.12.1349","article-title":"A novel subpopulation of CD45RA++","volume":"12","author":"Kanegane","year":"1991","journal-title":"Int. Immunol."},{"key":"10.1006\/clin.1998.4524_II984524RF10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/348163a0","article-title":"Interconversion of CD45R subsets of CD4 T cellsin vivo.","volume":"348","author":"Bell","year":"1990","journal-title":"Nature"},{"key":"10.1006\/clin.1998.4524_II984524RF11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2249.1992.tb03014.x","article-title":"Evidence for the presence of activated CD4 T cells with naive phenotype in the peripheral blood of patients with rheumatoid arthritis","volume":"87","author":"Maurer","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1998.4524_II984524RF12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/jcem-62-2-403","article-title":"Activated (Ia+","volume":"62","author":"Chan","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/clin.1998.4524_II984524RF13","first-page":"502","article-title":"Circulating activated T cell subsets in autoimmune thyroid diseases: differences between untreated and treated patients","volume":"125","author":"Ohashi","year":"1991","journal-title":"Acta Endocrinol."},{"key":"10.1006\/clin.1998.4524_II984524RF14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0090-1229(89)90164-5","article-title":"Intrathyroidal HLA-DR-positive lymphocytes in Hashimoto's disease: increases in CD8 and Leu7 cells","volume":"52","author":"Aozasa","year":"1989","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1006\/clin.1998.4524_II984524RF15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1210\/jcem-56-1-164","article-title":"Peripheral blood and intrathyroidal mononuclear cell populations in patients with autoimmune thyroid disorders enumerated using monoclonal antibodies","volume":"56","author":"Wall","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/clin.1998.4524_II984524RF16","first-page":"282","article-title":"Existence and immunological significance of circulating la+","volume":"115","author":"Zeki","year":"1987","journal-title":"Acta Endocrinol."},{"key":"10.1006\/clin.1998.4524_II984524RF17","first-page":"493","article-title":"Immunity in Graves\u2019 disease at diagnosis: correlation between activated T cells and humoral immune factors","volume":"113","author":"Di Mario","year":"1986","journal-title":"Acta Endocrinol."},{"key":"10.1006\/clin.1998.4524_II984524RF18","first-page":"377","article-title":"Activated T cells in Graves\u2019 disease before treatment","volume":"59","author":"Kennedy","year":"1985","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1998.4524_II984524RF19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0090-1229(83)90160-5","article-title":"Circulating T-cell subsets in Graves\u2019 disease: differences between patients with active disease and in remission after131","volume":"28","author":"Canonica","year":"1983","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1006\/clin.1998.4524_II984524RF20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/jcem-59-2-187","article-title":"Ia+","volume":"59","author":"Jackson","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/clin.1998.4524_II984524RF21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198701013160104","article-title":"Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves\u2019 disease","volume":"316","author":"T\u00f6ttermann","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clin.1998.4524_II984524RF22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/bmj.288.6416.526","article-title":"Analysis of T cell subsets in Graves\u2019 disease: alterations associated with carbimazole","volume":"288","author":"Ludgate","year":"1984","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"10.1006\/clin.1998.4524_II984524RF23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jcem-65-1-17","article-title":"Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves\u2019 disease","volume":"65","author":"Ishikawa","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/clin.1998.4524_II984524RF24","first-page":"233","article-title":"Peripheral blood T cell activation after radioiodine treatment for Graves\u2019 disease","volume":"122","author":"Teng","year":"1990","journal-title":"Acta Endocrinol."},{"key":"10.1006\/clin.1998.4524_II984524RF25","first-page":"258","article-title":"Immunomodulation by methimazole therapy in Graves\u2019 disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells","volume":"74","author":"Karlsson","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1998.4524_II984524RF26","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/iai.63.8.2941-2949.1995","article-title":"Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease","volume":"63","author":"Islam","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1006\/clin.1998.4524_II984524RF27","first-page":"147","article-title":"Graves\u2019 ophthalmopathy and tobacco smoking","volume":"129","author":"Tallstedt","year":"1993","journal-title":"Acta Endocrinol."},{"key":"10.1006\/clin.1998.4524_II984524RF28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cyto.990140614","article-title":"CD4 T-lymphocyte determinations on whole blood specimens using a single-tube three color assay","volume":"14","author":"Nicholson","year":"1993","journal-title":"Cytometry"},{"key":"10.1006\/clin.1998.4524_II984524RF29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-1759(92)90206-9","article-title":"Lymphocyte immunophenotyping by flow cytometry in normal adults. Comparison of fresh whole blood lysis technique, Ficoll-Paque separation and cryopreservation","volume":"154","author":"Romeu","year":"1992","journal-title":"J. Immunol. Methods"},{"key":"10.1006\/clin.1998.4524_II984524RF30","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/diacare.19.11.1177","article-title":"Persistent activation of CD8+","volume":"19","author":"Peakman","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1006\/clin.1998.4524_II984524RF31","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1126\/science.272.5270.1947","article-title":"Induction of bystander T cell proliferation by viruses and type I interferonin vivo","volume":"272","author":"Tough","year":"1996","journal-title":"Science"},{"key":"10.1006\/clin.1998.4524_II984524RF32","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/diab.44.12.1414","article-title":"Aberrant activation of CD8++","volume":"44","author":"Hehmke","year":"1995","journal-title":"Diabetes"},{"key":"10.1006\/clin.1998.4524_II984524RF33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4049\/jimmunol.150.2.429","article-title":"Both CD45RA+\u2212+","volume":"150","author":"Okumura","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1998.4524_II984524RF34","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1172\/JCI117892","article-title":"CD8 naive T cell counts decrease progressively in HIV-infected adults","volume":"95","author":"Roederer","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1006\/clin.1998.4524_II984524RF35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2337\/diab.42.1.127","article-title":"Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM","volume":"42","author":"Smerdon","year":"1993","journal-title":"Diabetes"},{"key":"10.1006\/clin.1998.4524_II984524RF36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/thy.1994.4.217","article-title":"Evidence that the immunosuppressive effects of antithyroid drugs are mediated through actions on the thyroid cell, modulating thyrocyte-immunocyte signaling: a review","volume":"4","author":"Volp\u00e9","year":"1994","journal-title":"Thyroid"},{"key":"10.1006\/clin.1998.4524_II984524RF37","first-page":"111","article-title":"Inhibition of the receptor for interleukin-2 induced by carbimazole: relevance for the therapy of autoimmune thyroid disease","volume":"60","author":"Signore","year":"1985","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1998.4524_II984524RF38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.1996.6.29","article-title":"Methimazole has no dose-related effect on the serum concentrations of soluble class I major histocompatibility complex antigens, soluble interleukin-2 receptor, and \u03b22","volume":"6","author":"Escobar-Morreale","year":"1996","journal-title":"Thyroid"},{"key":"10.1006\/clin.1998.4524_II984524RF39","first-page":"2122","article-title":"Circulating selectins, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in hyperthyroidism","volume":"80","author":"Wenisch","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/clin.1998.4524_II984524RF40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1089\/thy.1994.4.145","article-title":"The immunomodulatory effects of antithyroid drugs","volume":"4","author":"Weetman","year":"1994","journal-title":"Thyroid"},{"key":"10.1006\/clin.1998.4524_II984524RF41","first-page":"1516","article-title":"A prospective randomized trial of antithyroid drug dose in Graves\u2019 disease therapy","volume":"76","author":"Reinwein","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/clin.1998.4524_II984524RF42","first-page":"2470","article-title":"Methimazole has no dose-related effect on the intensity of the intrathyroidal autoimmune process in relapsing Graves\u2019 disease","volume":"80","author":"Paschke","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1006\/clin.1998.4524_II984524RF43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/edrv-5-2-309","article-title":"Autoimmune thyroid disease: developments in our understanding","volume":"5","author":"Weetman","year":"1984","journal-title":"Endocr. Rev."},{"key":"10.1006\/clin.1998.4524_II984524RF44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(05)65600-0","article-title":"Is there one successful antithyroid regimen for Graves\u2019 disease","volume":"348","author":"Braverman","year":"1996","journal-title":"Lancet"},{"key":"10.1006\/clin.1998.4524_II984524RF45","first-page":"337","article-title":"The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves\u2019 patients is secondary to the hyperthyroidism","volume":"10","author":"Gerstein","year":"1987","journal-title":"Clin. Invest. Med."},{"key":"10.1006\/clin.1998.4524_II984524RF46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.1989.tb01244.x","article-title":"Scottish Automated Follow-Up Register Group), Antithyroid drugs in the treatment of hyperthyroidism of Graves\u2019 disease: long-term follow-up of 434 patients","volume":"31","author":"Hedley","year":"1989","journal-title":"Clin. Endocrinol."}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009012299894524X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009012299894524X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:09:23Z","timestamp":1758762563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009012299894524X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["S009012299894524X"],"URL":"https:\/\/doi.org\/10.1006\/clin.1998.4524","relation":{},"ISSN":["0090-1229"],"issn-type":[{"value":"0090-1229","type":"print"}],"subject":[],"published":{"date-parts":[[1998,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated CD69 Expression on Naive Peripheral Blood T-Cells in Hyperthyroid Graves\u2019 Disease and Autoimmune Thyroiditis: Discordant Effect of Methimazole on HLA-DR and CD69","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1998.4524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}